ALEXANDRA RATELIFF: Open Payments
NPI 1003302936 · SURFSIDE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 23 payments from 10 companies in 2025. Trend: 2023 $406 · 2024 $249 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $196 |
| GlaxoSmithKline, LLC. | 5 | $91 |
| Optinose US, Inc. | 3 | $57 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $48 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Stryker Corporation | 1 | $23 |
| Medtronic, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Inspire Medical Systems, Inc. | 1 | $14 |
Products named: DUPIXENT, NUCALA, Xhance, NEFFY, KEYTRUDA, LATERA, PROPEL, TEZSPIRE.
Industry payments across SC — which companies pay providers there.
